IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Boone Capital Management LLC

Q2 2026 Holdings

Filed 2026-08-14 | 16 holdings | $427.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Teleflex Incorporated(TFX)COM879369106$49.1M387,38811.5%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$48.7M415,64111.4%
The Cigna Group(CI)COM125523100$43.9M159,29010.3%
Ionis Pharmaceuticals Inc(IONS)COM462222100$41.2M519,9779.6%
Unitedhealth Group Inc(UNH)COM91324P102$36.9M88,6878.6%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$33.4M583,2197.8%
Guardian Pharmacy Svcs Inc(GRDN)CL A40145W101$29.8M711,9397.0%
Vestis Corporation(VSTS)COM SHS29430C102$27.6M1,900,1406.5%
Bridgebio Pharma Inc(BBIO)COM10806X102$25.3M339,7205.9%
Pennant Group Inc(PNTG)COM70805E109$19.1M515,8184.5%
Monte Rosa Therapeutics Inc(GLUE)COM61225M102$14.9M615,2873.5%
Kodiak Sciences Inc(KOD)COM50015M109$14.7M378,0103.4%
Tango Therapeutics Inc(TNGX)COM87583X109$14.2M455,6053.3%
Kymera Therapeutics Inc(KYMR)COM501575104$13.0M113,1733.0%
Cullinan Therapeutics Inc(CGEM)COM230031106$12.8M704,4423.0%
Adlai Nortye LTD(ANL)SPONSORED ADS00704R109$3.0M258,3900.7%